Skip to main content
Top
Published in: Diabetology & Metabolic Syndrome 1/2015

Open Access 01-12-2015 | Meeting abstract

Loss of muscle strength in community-dwelling elderly is associated with type 2 diabetes

Authors: Valéria Pagotto, Daniella Moreira Dias, Kassyla Ferreira dos Santos, Joyce Gabriella Menezes Silva, Wanessa Freitas Silva, Erika Aparecida da Silveira

Published in: Diabetology & Metabolic Syndrome | Special Issue 1/2015

Login to get access

Excerpt

A loss of skeletal muscle mass and strength is frequently observed in older adults. Persons with diabetes have accelerated muscle and strength loss, but the relationship of hyperglycemia to declines in muscle function has not been explored yet. …
Metadata
Title
Loss of muscle strength in community-dwelling elderly is associated with type 2 diabetes
Authors
Valéria Pagotto
Daniella Moreira Dias
Kassyla Ferreira dos Santos
Joyce Gabriella Menezes Silva
Wanessa Freitas Silva
Erika Aparecida da Silveira
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Diabetology & Metabolic Syndrome / Issue Special Issue 1/2015
Electronic ISSN: 1758-5996
DOI
https://doi.org/10.1186/1758-5996-7-S1-A39

Other articles of this Special Issue 1/2015

Diabetology & Metabolic Syndrome 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine